Please wait a minute...
文章检索
预防医学  2024, Vol. 36 Issue (6): 501-505    DOI: 10.19485/j.cnki.issn2096-5087.2024.06.010
  疾病控制 本期目录 | 过刊浏览 | 高级检索 |
上城区结直肠癌筛查结果分析
蒋鸣孝, 李剑, 黄旭云
杭州市上城区疾病预防控制中心疾控科,浙江 杭州 310000
Analysis of colorectal cancer screening results in Shangcheng District
JIANG Mingxiao, LI Jian, HUANG Xuyun
Department of Disease Control and Prevention, Shangcheng District Center for Disease Control and Prevention, Hangzhou, Zhejiang 310000, China
全文: PDF(787 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 目的 了解2020—2022年杭州市上城区结直肠癌筛查结果,为制定结直肠癌防制策略提供依据。方法 按照浙江省重点人群结直肠癌筛查项目要求,选择上城区50~74岁常住户籍居民为筛查对象,采用《浙江省重点人群结直肠癌筛查风险评估问卷》和免疫法粪便潜血试验(FIT)筛查,问卷阳性、FIT阳性、问卷和FIT阳性均为筛查阳性,筛查阳性居民进行结肠镜检查;分析筛查阳性率、结肠镜检查依从率、不同病理诊断结果的检出率。结果 2020—2022年上城区参与结直肠癌筛查118 227人,筛查阳性18 913人,筛查阳性率为16.00%,其中问卷阳性率、FIT阳性率、问卷和FIT阳性率分别为8.14%、6.46%和1.40%。6 501人完成结肠镜检查,依从率为34.37%。检出结直肠病变3 689例,检出率为56.75%,其中结直肠癌检出率、癌前病变检出率和其他良性病变检出率分别为1.12%、9.15%和46.47%。男性筛查阳性、结直肠病变检出率和癌前病变检出率(22.16%、61.25%和12.45%)高于女性(11.62%、51.98%和5.67%);筛查阳性率、结直肠病变检出率、结直肠癌检出率和癌前病变检出率随年龄增长呈上升趋势;2020—2022年筛查阳性率、结直肠病变检出率呈下降趋势,结肠镜检查依从率呈上升趋势;问卷和FIT阳性居民结直肠病变检出率较高,为65.37%(均P<0.05)。结论 2020—2022年上城区结直肠癌检出率为1.12%,癌前病变为9.15%,男性、老年人、问卷和FIT阳性居民为重点人群,应提高结肠镜检查依从性。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
蒋鸣孝
李剑
黄旭云
关键词 结直肠癌癌前病变筛查依从性    
AbstractObjective To analyze the status of colorectal cancer screening results in Shangcheng District, Hangzhou City from 2020 to 2022, so as to provide the evidence for developing prevention and control strategies for colorectal cancer. Methods According to Colorectal Cancer Screening Program for Zhejiang Key Populations, residents registered in Shangcheng District and at ages of 50 to 74 years were recruited and screened using Zhejiang Provincial Questionnaires for Assessment of Risk of Colorectal Cancer Screening among High-risk Populations and fecal immunochemical test (FIT). Residents positive for questionnaires or FIT, or both positive for questionnaires and FIT were served as a positive screening and colonoscopy should be underwent. The rates of positive screening, compliance of colonoscopy and different pathological diagnosis results were analyzed. Results Totally 118 227 residents were screened in Shangcheng District from 2020 to 2022, with a positive rate of 16.00%. The positive rates of questionnaires, FIT and both questionnaires and FIT were 8.14%, 6.46% and 1.40%, respectively. Colonoscopy was performed among 6 501 cases, with a compliance rate of 34.37%. Colonoscopy detected 3 689 cases with colorectal lesions, with a detection rate of 56.75%. The detection rates of colorectal cancer, pericancer lesions and other benign lesions were 1.12%, 9.15% and 46.47%, respectively. The detection rates of positive screening, colorectal lesions and pericancer lesions were higher in men (22.16%, 61.25% and 12.45%) than those in women (11.62%, 51.98% and 5.67%; all P<0.05). The detection rates of positive screening, colorectal lesions, colorectal cancer and pericancer lesions appeared a tendency towards a rise with age (all P<0.05). The detection rates of positive screening and colorectal lesions appeared a tendency towards a decline, and the compliance rate of colonoscopy appeared a tendency towards a rise from 2020 to 2022 (all P<0.05). The detection rate of pericancer lesions was higher among questionnaire and FIT positive residents (65.37%, P<0.05). Conclusions The detection rates of colorectal cancer and pericancer lesions in Shangcheng District from 2020 to 2022 were 1.12% and 9.15%, respectively. Men, the elderly, questionnaire and FIT positive residents are key populations, and the compliance of colonoscopy for the populations should be improved.
Key wordscolorectal cancer    pericancer lesions    screening    compliance
收稿日期: 2024-03-07      修回日期: 2024-05-14      出版日期: 2024-06-10
中图分类号:  R195.4  
作者简介: 蒋鸣孝,本科,主管医师,主要从事疾病预防控制工作
通信作者: 李剑,E-mail:578694077@qq.com   
引用本文:   
蒋鸣孝, 李剑, 黄旭云. 上城区结直肠癌筛查结果分析[J]. 预防医学, 2024, 36(6): 501-505.
JIANG Mingxiao, LI Jian, HUANG Xuyun. Analysis of colorectal cancer screening results in Shangcheng District. Preventive Medicine, 2024, 36(6): 501-505.
链接本文:  
http://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2024.06.010      或      http://www.zjyfyxzz.com/CN/Y2024/V36/I6/501
[1] XU L Y,ZHAO J H,LI Z H,et al.National and subnational incidence,mortality and associated factors of colorectal cancer in China:a systematic analysis and modelling study[J/OL].J Glob Health,2023,13[2024-05-14].https://doi.org/10.7189/jogh.13.04096.
[2] HAN B F,ZHENG R S,ZENG H M,et al.Cancer incidence and mortality in China,2022[J].J Natl,2024,4(1):47-53.
[3] 程向东,杜灵彬.2022浙江省肿瘤登记年报[M].北京:清华大学出版社,2023.
[4] SIEGEL R L,WAGLE N S,CERCEK A,et al.Colorectal cancer statistics,2023[J].CA Cancer J Clin,2023,73:233-254.
[5] 张芃,蒋虹丽,陈文,等.大肠癌人群筛查项目实施的国际进展[J].上海预防医学,2021,33(4):273-279.
[6] 朱陈,龚巍巍,钟节鸣,等.浙江省重点人群结直肠癌筛查项目设计和实施方案[J].中国肿瘤,2020,29(12):899-903.
[7] 柏愚,杨帆,马丹,等.中国早期结直肠癌筛查及内镜诊治指南(2014年,北京)[J].胃肠病学,2015,20(6):345-365.
[8] 郑沛,卢丽微,朱福乾,等.永嘉县结直肠癌筛查结果分析[J].预防医学,2022,34(7):727-731.
[9] 和金金,朱陈,潘婷婷,等.定性和定量粪便免疫化学试验筛查结直肠癌效果评价[J].预防医学,2024,36(4):317-321.
[10] 国家癌症中心中国结直肠癌筛查与早诊早治指南制定专家组.中国结直肠癌筛查与早诊早治指南(2020,北京)[J].中华肿瘤杂志,2021,43(1):16-38.
[11] 梅少林,刘晓红,杜冬明,等.丽水市居民结直肠癌发病与死亡趋势分析[J].预防医学,2020,32(7):666-669.
[12] 杨金华,沈飞琼,薛峰,等.2007—2016年浙江省嘉善县结直肠癌筛查方案应用评价[J].中国肿瘤,2020,29(12):919-924.
[13] 杨会棉,李超楠,林恒娜.2016—2019年北京市门头沟区结直肠癌筛查结果分析[J].社区医学杂志,2021,19(23):1391-1394.
[14] 洪尚游. 大肠癌结肠镜筛查的策略及依从性研究[D].上海:第二军医大学,2012.
[15] 许文敏. 广州市结直肠癌筛查策略评估及肠镜结果分析[D].广州:广州医科大学,2020.
[16] 杜倩,邵春昕,邹赤群,等.2015—2021年北京市通州区结直肠癌早诊早治筛查结果分析[J].中国肿瘤,2023,32(9):698-702.
[17] 蓝柳豪,徐美慧,吴胜智,等.2018—2019年浙江省兰溪市结直肠癌筛查不同方案筛查效果的比较[J].中国肿瘤,2023,32(3):209-218.
[18] 高以焕,孔蕴馨,董栋,等.风险评分模型、免疫法粪便隐血试验及二者联合筛查方案在徐州市人群结直肠癌筛查中的检出率比较[J].现代预防医学,2023,50(5):954-960.
[1] 梁薇, 任梦婷, 张文科, 杨琳, 王红雨. 滁州市中小学生脊柱侧弯筛查结果[J]. 预防医学, 2024, 36(7): 607-610.
[2] 葛晓蕾, 张伟波, 陈春梅, 朱有为, 刘彦丽, 谢斌, 蔡军, 朱益. 长效抗精神病药物治疗的精神分裂症病例分析[J]. 预防医学, 2024, 36(5): 412-415.
[3] 和金金, 朱陈, 潘婷婷, 黄文雯, 蒋秉洁, 余炜燕, 王乐, 吴维妙, 杭栋, 杜灵彬. 定性和定量粪便免疫化学试验筛查结直肠癌效果评价[J]. 预防医学, 2024, 36(4): 317-321.
[4] 胡军路, 冯慧慧, 陈文迪. 献血前健康筛查软件介绍及应用[J]. 预防医学, 2024, 36(4): 362-364.
[5] 陈淑淑, 龚巍巍, 关云琦, 周晓燕, 潘劲, 戴品远, 王浩, 李娜, 俞敏. 1990—2019年浙江省结直肠癌疾病负担和危险因素分析[J]. 预防医学, 2024, 36(3): 203-206.
[6] 高菡璐, 俞晓芳, 吕乐彬, 叶国良, 樊金卿. 多靶点粪便DNA、肠道菌群、癌胚抗原及水果摄入对结直肠癌风险的交互作用研究[J]. 预防医学, 2024, 36(3): 219-223.
[7] 牛贺, 王荣环, 鲍筝. 北京市通州区0~3岁儿童发育筛查结果[J]. 预防医学, 2024, 36(2): 165-168.
[8] 徐亚华, 吴斌. 兰溪市120例HIV抗体筛查阳性样本确证结果分析[J]. 预防医学, 2023, 35(6): 538-540.
[9] 曾龙武, 唐晓鸿, 张素霞, 刘强, 梁朝聪, 唐漫漫. 结直肠癌化疗患者照护人疾病不确定感影响因素分析[J]. 预防医学, 2023, 35(5): 444-447.
[10] 张红, 胡志明, 潘晓锋, 朱梦胜, 戴伟丽, 谢伊丽, 诸建方. 社区高血压患者Triangle分层分级管理效果评价[J]. 预防医学, 2023, 35(4): 350-354,358.
[11] 吕乐彬, 樊金卿, 赵王芳, 陆启文, 顾俊娣, 高菡璐. 肠镜检查人群多靶点粪便DNA检测意愿的影响因素分析[J]. 预防医学, 2023, 35(3): 218-223.
[12] 徐云辉, 应丹丹, 杨静. 中青年脑卒中患者功能锻炼依从性研究[J]. 预防医学, 2023, 35(2): 171-175.
[13] 罗发燕, 陈铁霞, 罗平平, 诸伟红. 慢性乙型肝炎患者服药依从性调查[J]. 预防医学, 2023, 35(11): 966-969,974.
[14] 彭迁, 罗美玲, 张英. 我国HIV/AIDS病例抗病毒治疗依从性的Meta分析[J]. 预防医学, 2023, 35(11): 975-980.
[15] 王川, 赵秋玲, 马艳艳, 高倩, 赵月, 罗佳. 2012—2021年朝阳区新生儿遗传代谢病筛查工作质量评价[J]. 预防医学, 2023, 35(11): 1001-1004.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed